重庆市基本药物集中采购政策对药品价格的影响机制研究  

Study on the Influence Mechanism of Essential Medicine Centralized Purchasing Policy on Medicine Price in Chongqing

作　　者：杨文[1,2] 代涛[2] 陈瑶[2] 白冰[2] 

机构地区：[1]北京协和医学院,北京100730 [2]中国医学科学院医学信息研究所/卫生政策与管理研究中心,北京100020

出　　处：《中国药房》2015年第12期1604-1607,共4页China Pharmacy

摘　　要：目的:研究重庆市以药品交易所(以下简称药交所)为平台的基本药物集中采购政策对药品价格的影响,为完善我国药品集中采购政策提出建议。方法:列表比较重庆市以药交所为平台实施集中采购基本药物政策前后的基本药物价格,并将采用世界卫生组织/国际健康行动机构标准调查法获得的价格数据与国际参考价格进行比较。结果:重庆市实施药交所平台集中采购基本药物后,除小部分低价基本药物价格较实施前有所升高外,大部分基本药物的价格均降低,但是总体上基本药物的价格仍要高于国际参考价格。结论:通过制定入市价、挂牌价、成交价的价格约束机制,重庆市基本药物价格逐渐趋于合理,但与国际参考价格仍有一定差距。建议进一步构建科学的基本药物采购价格形成机制,扩大药交所规模效益,提高市场集中度和配送效率,加强药品价格和配送监管,以保障基本药物的可及性。OBJECTIVE：To research the influence mechanism of essential medicines centralized purchasing policy（EMCPP）on medicine price with the platform of Pharmaceutical Exchange（hereinafter referred to Medicine Delivery） in Chongqing and make recommendations for improving the centralized purchasing policy in China. METHODS：The price of essential medicines in Chongqing before and after EMCPP was listed and compared,and the price data collected by WHO/HAI standard survey was compared with the international reference price（IRP）. RESULTS：After implementation of EMCPP in Chongqing,except the price of small parts of low-price essential medicines was increased than before,most essential medicines were decreased in price. But the price of essential medicines was still generally higher than IRP. CONCLUSIONS：According to the price constraint mechanism of into-market-price,listing-price,deal-price implementation,the price of essential medicines in Chongqing is gradually rationalized;but compared with the IRP,there are still some gaps. It is suggested to further establish the scientific pricing mechanism,expand exchange＇s economies of scale,improve the market concentration and the distribution efficiency and strengthen the monitoring of medicine price and distribution to ensure the accessibility of essential medicines.

关 键 词：基本药物 集中采购 价格 影响机制 

分 类 号：R197.3[医药卫生—卫生事业管理]